Skip to main content
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC logo

OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC — Investor Relations & Filings

Ticker · OCTHF ISIN · GB00BMVMRB86 LEI · 2138005SRWT4998BCE35 IL Manufacturing
Open in API
Filings indexed 176 across all filing types
Latest filing 2022-06-29 Regulatory Filings
Country GB United Kingdom
Listing IL OCTHF

About OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC

https://www.oxcantech.com/

Oxford Cannabinoid Technologies Holdings PLC was a biopharmaceutical company engaged in the research, development, and commercialization of cannabinoid-based prescription medicines. The company's primary focus was on the pain market, with the goal of developing non-addictive medications to reduce reliance on opioids. Its drug discovery programs targeted the endocannabinoid system (ECS) and included a portfolio of proprietary cannabinoid derivatives, in-licensed compounds, and new chemical entities. According to its website, the company ceased trading and entered administration in May 2025.

Recent filings

Filing Released Lang Actions
Trading Update
Regulatory Filings Classification · 98% confidence The document is identified by the RNS Number (5288Q) and the header 'National Storage Mechanism', indicating it is a regulatory announcement disseminated via the London Stock Exchange's RNS service. The content is titled 'Trading Update' and provides a summary of operational highlights, financial expectations (costs, cash position) for an eleven-month period ended April 30, 2022, and outlook statements. This is not a full Annual Report (10-K) or a comprehensive Interim Report (IR). It is a periodic update on business performance and financial expectations, which aligns best with an Earnings Release (ER) which typically provides key highlights before a full report, or potentially a Regulatory Filing (RNS) if it doesn't fit ER. Given the nature of a 'Trading Update' summarizing financial performance for a period, ER is a strong candidate. However, since it is explicitly distributed via RNS and contains general business updates alongside financial figures, and is not explicitly labeled as an 'Earnings Release' but rather a 'Trading Update', the most accurate general category for a non-standard, periodic regulatory update is RNS, although ER is closely related. Since it provides financial highlights and operational progress, it functions similarly to an ER. Given the context of providing key financial metrics (£5.6m costs, £9.2m cash) for a defined period, ER is more specific than the general RNS fallback. I will classify it as ER, as trading updates often serve as preliminary earnings announcements.
2022-06-29 English
Second Price Monitoring Extn
Interest Rate Update/Notice Classification · 99% confidence The document is very short (1943 characters) and is titled 'Second Price Monitoring Extension' under the 'RNS Number' heading. It describes an operational event related to trading ('auction call period is extended', 'price monitoring extension') and explicitly states that the information is provided by RNS, the news service of the London Stock Exchange, which is approved by the FCA as a Primary Information Provider. This is a general regulatory announcement that does not fit the specific definitions for financial reports (10-K, IR, ER), management changes (MANG), or shareholder actions (DIV, DVA). Therefore, it falls best under the general Regulatory Filings category (RNS).
2022-05-30 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1926 characters) and contains the header 'RNS Number : 2928N' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content describes a 'Price Monitoring Extension' for a security, which is a specific, non-standard regulatory event notification. Since it is a brief, specific regulatory announcement that doesn't fit into the major categories (like 10-K, ER, or DIV), it falls best under the general regulatory announcement category, RNS.
2022-05-30 English
New Broker and Investor Presentation
Regulatory Filings Classification · 99% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content announces two distinct items: the appointment of a corporate broker (Axis Capital Markets) and a Notice of an upcoming Investor Meet Company Live Q&A Session. Since this is a short, specific announcement released via the London Stock Exchange's regulatory news service (RNS) that does not fit into the specific categories like ER, 10-K, or DIV, it falls best under the general regulatory announcement category.
2022-05-16 English
Formation of Scientific Advisory Board
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated April 25, 2022. It announces the 'Formation of Scientific Advisory Board to Support Clinical Strategy' for Oxford Cannabinoid Technologies Holdings plc. The content is a press release detailing a strategic operational update (forming an SAB and its role in upcoming clinical trials). This type of announcement, which is not a formal financial report (like 10-K or IR), dividend notice, or management change, fits best under the general category for regulatory news releases that don't have a more specific code. Since it is a formal announcement distributed via RNS (London Stock Exchange's news service), and it doesn't fit definitions like MANG, ER, or CAP, the most appropriate classification is the general regulatory filing/announcement category, RNS.
2022-04-25 English
[change-account-reference-date-company-current-shortened] made_up_date=2022-05-31, new_date=2022-04-30
Regulatory Filings
2022-04-12 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.